Lantus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Trial Comparing the Pharmacodynamics and Pharmacokinetics of BC Combo THDB0207 and Lantus ® and Humalog® in Subjects With Type 1 Diabetes
Condition: Type 1 Diabetes Interventions: Drug: Euglycemic clamp with BC Combo THDB0207; Drug: Euglycemic clamp with Lantus®; Drug: Euglycemic clamp with Humalog® Sponsors: Adocia; Tonghua Dongbao Pharmaceutical Co.,Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2022 Category: Research Source Type: clinical trials

A Trial Comparing the Pharmacodynamics and Pharmacokinetics of BC Combo THDB0207 and Lantus ® and Humalog® in Subjects With Type 1 Diabetes
Condition: Type 1 Diabetes Interventions: Drug: Euglycemic clamp with BC Combo THDB0207; Drug: Euglycemic clamp with Lantus®; Drug: Euglycemic clamp with Humalog® Sponsors: Adocia; Tonghua Dongbao Pharmaceutical Co.,Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2022 Category: Research Source Type: clinical trials

A Study to Demonstrate Pharmacokinetic and Pharmacodynamic Biosimilarity Between HEC-Glargine and US-Lantus ® in Healthy Male Volunteers
Conditions: Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus Interventions: Drug: HEC-Glargine; Drug: US-Lantus Sponsors: Lannett Company, Inc.; Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2022 Category: Research Source Type: clinical trials